Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'protease inhibitors' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1899 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pomerantz, RJ
      Reservoirs of human immunodeficiency virus type 1: The main obstacles to viral eradication

      CLINICAL INFECTIOUS DISEASES
    2. David, MH; Hornung, R; Fichtenbaum, CJ
      Ischemic cardiovascular disease in persons with human immunodeficiency virus infection

      CLINICAL INFECTIOUS DISEASES
    3. Vioque, J; Sanchez-Vioque, R; Clemente, A; Pedroche, J; Yust, MM; Millan, F
      Alcalase rapeseed inhibitors: Purification and partial characterization

      JOURNAL OF ENZYME INHIBITION
    4. Hutter, G; Sinha, P
      Proteomics for studying cancer cells and the development of chemoresistance

      PROTEOMICS
    5. Patel, RN
      Enzymatic synthesis of chiral intermediates for drug development

      ADVANCED SYNTHESIS & CATALYSIS
    6. Bos, IGAC; van Mierlo, GJ; Bleeker, WK; Rigter, GMM; Velthuis, HT; Dickneite, G; Hack, CE
      The potentiation of human C1-inhibitor by dextran sulphate is transient invivo: studies in a rat model

      INTERNATIONAL IMMUNOPHARMACOLOGY
    7. Korver, GE; Kam, CM; Powers, JC; Hudig, D
      Dipeptide vinyl sulfones suitable for intracellular inhibition of dipeptidyl peptidase I

      INTERNATIONAL IMMUNOPHARMACOLOGY
    8. Bell, HA; Fitches, EC; Down, RE; Ford, L; Marris, GC; Edwards, JP; Gatehouse, JA; Gatehouse, AMR
      Effect of dietary cowpea trypsin inhibitor (CpTI) on the growth and development of the tomato moth Lacanobia oleracea (Lepidoptera : Noctuidae) and on the success of the gregarious ectoparasitoid Eulophus pennicornis (Hymenoptera : Eulophidae)

      PEST MANAGEMENT SCIENCE
    9. Mahajan, AP; Tashima, KT; Bausserman, LL; Flynn, MM; Carpenter, CCJ
      Plateau in body habitus changes and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy: A 3.5-year study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Servais, J; Nkoghe, T; Schmit, JC; Arendt, V; Robert, I; Staub, T; Moutschen, M; Schneider, F; Hemmer, R
      HIV-associated hematologic disorders are correlated with plasma viral loadand improve under highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Kennedy, BL; O'Malley, J; Khanlou, H; Farthing, C
      Heterogeneity of patients' adherence profile to antiretroviral therapy in HIV-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Monforte, AD; Bugarini, R; Pezzotti, P; De Luca, A; Antinori, A; Mussini, C; Vigevani, GM; Tirelli, U; Bruno, R; Gritti, F; Piazza, M; Chigiotti, S; Chirianni, A; De Stefano, C; Pizzigallo, E; Perrella, O; Moroni, M
      Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Tozzi, V; Balestra, T; Galgani, S; Narciso, P; Sampaolesi, A; Antinori, A; Giulianelli, M; Serraino, I; Ippolito, G
      Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    14. Altice, FL; Mostashari, F; Friedland, GH
      Trust and the acceptance of and adherence to antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    15. Nunez, M; Lana, R; Mendoza, JL; Martin-Carbonero, L; Soriano, V
      Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    16. Rakotoambinina, B; Medioni, J; Rabian, C; Jubault, V; Jais, JP; Viard, JP
      Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    17. Rey, D; Schmitt, MP; Partisani, M; Hess-Kempf, G; Krantz, W; de Mautort, E; Bernard-Henry, C; Priester, M; Cheneau, C; Lang, JM
      Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    18. Lucia, MB; Rutella, S; Leone, G; Vella, S; Cauda, R
      HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    19. Veldkamp, AI; van Heeswijk, RPG; Mulder, JW; Meenhorst, PL; Schreij, G; van der Geest, S; Lange, JMA; Beijnen, JH; Hoetelmans, RMW
      Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    20. Easterbrook, PJ; Newson, R; Ives, N; Pereira, S; Moyle, G; Gazzard, BG
      Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    21. Le Moing, V; Chene, G; Carrieri, MP; Besnier, JM; Masquelier, B; Salamon, R; Bazin, C; Moatti, JP; Raffi, F; Leport, C
      Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    22. Ruiz, L; Negredo, E; Domingo, P; Paredes, R; Francia, E; Balague, M; Gel, S; Bonjoch, A; Fumaz, CR; Johnston, S; Romeu, J; Lange, J; Clotet, B
      Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    23. Bogner, JR; Vielhauer, V; Beckmann, RA; Michl, G; Wille, L; Salzberger, B; Goebel, FD
      Stavudine versus zidovudine and the development of lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    24. Jensen-Fangel, S; Thomsen, HF; Larsen, L; Black, FT; Obel, N
      The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients - A prospective, open-label, controlled, randomized study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    25. Dube, MP; Edmondson-Melancon, H; Qian, D; Aqeel, R; Johnson, D; Buchanan, TA
      Prospective evaluation of the effect of initiating indinavir-based therapyon insulin sensitivity and B-cell function in HIV-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    26. Gerber, JG; Rosenkranz, S; Segal, Y; Aberg, J; D'Amico, R; Mildvan, D; Gulick, R; Hughes, V; Flexner, C; Aweeka, F; Hsu, A; Gal, J
      Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: Results of AIDS clinical trials group (ACTG) 401

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    27. Lu, J; Kuritzkes, DR
      A novel recombinant marker virus assay for comparing the relative fitness of HIV-1 reverse transcriptase variants

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    28. Mulligan, K; Tai, VW; Algren, H; Abrams, DI; Leiser, RJ; Lo, JC; Schambelan, M
      Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    29. Lewden, C; Raffi, F; Chene, G; Sobel, A; Leport, C
      Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy - Standardization to the general population

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    30. Weidle, PJ; Kityo, CM; Mugyenyi, P; Downing, R; Kebba, A; Pieniazek, D; Respess, R; Hertogs, K; De Vroey, V; Dehertogh, P; Bloor, S; Larder, B; Lackritz, E
      Resistance to antiretroviral therapy among patients in Uganda

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    31. Semba, RD; Shah, N; Vlahov, D
      Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    32. Para, MF; Kalish, LA; Collier, AC; Pollard, RB; Kumar, PN; Mintz, L; Wallach, FR; Drew, WL
      Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    33. Schmitz, M; Michl, GM; Walli, R; Bogner, J; Bedynek, A; Seidel, D; Goebel, FD; Demant, T
      Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    34. Duwe, S; Brunn, M; Altmann, D; Hamouda, O; Schmidt, B; Walter, H; Pauli, G; Kucherer, C
      Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    35. Tchetgen, E; Kaplan, EH; Friedland, GH
      Public health consequences of screening patients for adherence to highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    36. Millon, L; Drobacheff, C; Piarroux, R; Monod, M; Reboux, G; Laurent, R; Meillet, D
      Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    37. Briones, C; Perez-Olmeda, M; Rodriguez, C; del Romero, J; Hertogs, K; Soriano, V
      Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    38. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
      Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    39. Sprott, KT; McReynolds, MD; Hanson, PR
      A temporary phosphorus tether/ring-closing metathesis strategy to functionalized 1,4-diamines

      ORGANIC LETTERS
    40. Owens, TD; Semple, JE
      Atom-economical synthesis of the N(10)-C(17) fragment of cyclotheonamides via a novel passerini reaction-deprotection-acyl migration strategy

      ORGANIC LETTERS
    41. Bursavich, MG; West, CW; Rich, DH
      From peptides to non-peptide peptidomimetics: Design and synthesis of new piperidine inhibitors of aspartic peptidases

      ORGANIC LETTERS
    42. Montaner, LJ
      Structured treatment interruptions to control HIV-1 and limit drug exposure

      TRENDS IN IMMUNOLOGY
    43. Agu, RU; Ugwoke, MI; Armand, M; Kinget, R; Verbeke, N
      The lung as a route for systemic delivery of therapeutic proteins and peptides

      RESPIRATORY RESEARCH
    44. Gan, SK; Samaras, K; Carr, A; Chisholm, D
      Anti-retroviral therapy, insulin resistance and lipodystrophy

      DIABETES OBESITY & METABOLISM
    45. Drobacheff, C; Millon, L; Monod, M; Piarroux, R; Robinet, E; Laurent, R; Meillet, D
      Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    46. Enders, D; Teschner, P; Raabe, G; Runsink, J
      Asymmetric electrophilic substitutions at the alpha-position of gamma- anddelta-lactams

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    47. Schierle-Arndt, K; Kolter, D; Danielmeier, K; Steckhan, E
      Electrogenerated chiral 4-methoxy-2-oxazolidinones as diastereoselective amidoalkylation reagents for the synthesis of beta-amino alcohol precursors

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    48. Abudula, A; Rommerskirch, W; Weber, E; Gunther, D; Wiederanders, B
      Splice variants of human cathepsin L mRNA show different expression rates

      BIOLOGICAL CHEMISTRY
    49. Oliva, MLV; Santomauro-Vaz, EM; Andrade, SA; Juliano, MA; Pott, VJ; Sampaio, MU; Sampaio, CAM
      Synthetic peptides and fluorogenic substrates related to the reactive sitesequence of Kunitz-type inhibitors isolated from Bauhinia: Interaction with human plasma kallikrein

      BIOLOGICAL CHEMISTRY
    50. Clark, JM; Van Dyke, RE; Kurth, MC
      Tryptase inhibition

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    51. Gao, J; Sudoh, M; Aube, J; Borchardt, RT
      Transport characteristics of peptides and peptidomimetics: I. N-methylatedpeptides as substrates for the oligopeptide transporter and P-glycoproteinin the intestinal mucosa

      JOURNAL OF PEPTIDE RESEARCH
    52. Aarnoutse, RE; Wissen, CPWGMVV; Underberg, WJM; Kleinnijenhuis, J; Hekster, YA; Burger, DM
      High-performance liquid chromatography of HIV protease inhibitors in humanbiological matrices

      JOURNAL OF CHROMATOGRAPHY B
    53. Koch, N; Tamalet, C; Tivoli, N; Fantini, J; Yahi, N
      Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase

      JOURNAL OF CLINICAL VIROLOGY
    54. Cazzulo, JJ; Stoka, V; Turk, V
      The major cysteine proteinase of Trypanosoma cruzi: A valid target for chemotherapy of Chagas disease

      CURRENT PHARMACEUTICAL DESIGN
    55. Docampo, R
      Recent developments in the chemotherapy of Chagas' disease

      CURRENT PHARMACEUTICAL DESIGN
    56. Yang, HZ; Deng, YQ; Shi, F
      Synthesis of dialkylureas by electrocatalytical carbonylation of aliphaticamines under mild conditions

      JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL
    57. De Bernardis, F; Sullivan, PA; Cassone, A
      Aspartyl proteinases of Candida albicans and their role in pathogenicity

      MEDICAL MYCOLOGY
    58. Shahmanesh, M; Jaleel, H; DeSilva, Y; Ross, JDC; Caslake, M; Cramb, R
      Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype

      SEXUALLY TRANSMITTED INFECTIONS
    59. Taylor, S; Pereira, AS
      Antiretroviral drug concentrations in semen of HIV-1 infected men

      SEXUALLY TRANSMITTED INFECTIONS
    60. Buss, N; Cammack, N
      Measuring the effectiveness of antiretroviral agents

      ANTIVIRAL THERAPY
    61. Van Vaerenbergh, K; Debaisieux, L; De Cabooter, N; Declercq, C; Desmet, K; Fransen, K; Maes, B; Marissens, D; Miller, K; Muyldermans, G; Sprecher, S; Stuyver, L; Vaira, D; Verhofstede, C; Zissis, G; Van Ranst, M; De Clercq, E; Desmyter, J; Vandamme, AM
      Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium

      ANTIVIRAL THERAPY
    62. Pillay, D
      The emergence and epidemiology of resistance in the nucleoside-experiencedHIV-infected population

      ANTIVIRAL THERAPY
    63. Hoetelmans, R
      Pharmacological exposure and the development of drug resistance in HIV

      ANTIVIRAL THERAPY
    64. Matthews, DJ; Kopczynski, J
      Using model-system genetics for drug-based target discovery

      DRUG DISCOVERY TODAY
    65. Lucas, ACS; Bermejo, AM; Tabernero, MJ; Fernandez, P; Campora, P
      Influence of concomitant drugs on methadone elimination half-life in patients under a maintenance treatment

      ADDICTION BIOLOGY
    66. Garcia-Viejo, MA; Ruiz, M; Martinez, E
      Strategies for treating HIV-related lipodystrophy

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    67. Durand, R; Savel, J
      Dihydrofolate reductase inhibitors: new developments in antiparasitic chemotherapy

      EXPERT OPINION ON THERAPEUTIC PATENTS
    68. Lynch, GS
      Novel therapies for muscular dystrophy and other muscle wasting conditions

      EXPERT OPINION ON THERAPEUTIC PATENTS
    69. Dragovich, PS
      Recent advances in the development of human rhinovirus 3C protease inhibitors

      EXPERT OPINION ON THERAPEUTIC PATENTS
    70. Hube, B; Naglik, J
      Candida albicans proteinases: resolving the mystery of a gene family

      MICROBIOLOGY-SGM
    71. Hansten, PD; Levy, RH
      Role of P-glycoprotein and organic anion transporting polypeptides in drugabsorption and distribution - Focus on H-1-receptor antagonists

      CLINICAL DRUG INVESTIGATION
    72. Plosker, GL; Perry, CM; Goa, KL
      Efavirenz - A pharmacoeconomic review of its use in HIV infection

      PHARMACOECONOMICS
    73. Borderi, M; Verucchi, G; Tadolini, M; Spinosa, S; Fortunato, L; Talo, S; Chiodo, F
      Metabolic complications of HIV-1 antiretroviral therapy: The lipodystrophysyndrome

      MICROBIOLOGICA
    74. Regazzi, MB; Seminari, E; Villani, P; Carriero, PL; Montagna, M; Marubbi, F; Maserati, R
      Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile

      JOURNAL OF CHEMOTHERAPY
    75. Brito, LO; Lopes, AR; Parra, JRP; Terra, WR; Silva, MC
      Adaptation of tobacco budworm Heliothis virescens to proteinase inhibitorsmay be mediated by the synthesis of new proteinases

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
    76. Meredith, KL; Jeffe, DB; Mundy, LM; Fraser, VJ
      Sources influencing patients in their HIV medication decisions

      HEALTH EDUCATION & BEHAVIOR
    77. Semba, RD; Shah, N; Klein, RS; Mayer, KH; Schuman, P; Gardner, LI; Vlahov, D
      Highly active antiretroviral therapy associated with improved anemia amongHIV-infected women

      AIDS PATIENT CARE AND STDS
    78. Demmer, C
      Quality of life and risk perception among predominantly heterosexual, minority individuals with HIV/AIDS

      AIDS PATIENT CARE AND STDS
    79. Kodoth, S; Bakshi, S; Scimeca, P; Black, K; Pahwa, S
      Possible linkage of amprenavir with intracranial bleeding in an HIV-infected hemophiliac

      AIDS PATIENT CARE AND STDS
    80. Sension, MG; Farthing, C; Shaffer, AG; Graham, E; Siemon-Hryczyk, P; Pilson, RS
      Challenges of antiretroviral treatment in transient and drug-using populations: The SUN study

      AIDS PATIENT CARE AND STDS
    81. Sonza, S; Crowe, SM
      Reservoirs for HIV infection and their persistence in the face of undetectable viral load

      AIDS PATIENT CARE AND STDS
    82. Marchei, E; Pacifici, R; Tossini, G; Di Fava, R; Valvo, L; Zuccaro, P
      Simultaneous liquid chromatographic determination of Indinavir Saquinavir,and Ritonavir in human plasma with combined ultraviolet absorbance and electrochemical detection

      JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
    83. Geletko, SM; ZuWallack, AR
      Treatment of hyperlipidemia in HIV-infected patients

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    84. Wang, ZL; Ramin, SA; Tsai, C; Lui, P; Herbert, PJ; Kyeyune-Nyombi, E; Ruckle, HC; Beltz, RE; Sands, JF
      Detection of telomerase activity in prostatic fluid specimens

      UROLOGIC ONCOLOGY
    85. Goldman, DP; Leibowitz, AA; Joyce, GF; Shapiro, MF; Bozzette, SA
      The impact of state policy on the costs of HIV infection

      MEDICAL CARE RESEARCH AND REVIEW
    86. Burman, WJ; Jones, BE
      Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    87. Potetinova, JV; Milgotina, EI; Makarov, VA; Voyushina, TL
      Synthesis of modified peptides with C-terminal alpha-amino aldehydes

      RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
    88. Wendel, CS; Mohler, MJ; Kroesen, K; Ampel, NM; Gifford, AL; Coons, SJ
      Barriers to use of electronic adherence monitoring in an HIV clinic

      ANNALS OF PHARMACOTHERAPY
    89. Hughes, CA; Taylor, GD
      Metformin in an HIV-infected patient with protease inhibitor-induced diabetic ketoacidosis

      ANNALS OF PHARMACOTHERAPY
    90. James, CW; McNelis, KC; Cohen, DM; Szabo, S; Bincsik, AK
      Recurrent ingrown toenails secondary to indinavir/ritonavir combination therapy

      ANNALS OF PHARMACOTHERAPY
    91. John, L; Marra, F; Ensom, MHH
      Role of therapeutic drug monitoring for protease inhibitors

      ANNALS OF PHARMACOTHERAPY
    92. Abraham, PE; Sorensen, SJ; Baker, WH; Cushing, HE
      Nelfinavir desensitization

      ANNALS OF PHARMACOTHERAPY
    93. Manfredi, R; Calza, L; Chiodo, F
      Gynecomastia associated with highly active antiretroviral therapy

      ANNALS OF PHARMACOTHERAPY
    94. Torre, D; Tambini, R; Cadario, F; Barbarini, G; Moroni, M; Basilico, C
      Evolution of coinfection with human immunodeficiency virus and hepatitis Cvirus in patients treated with highly active antiretroviral therapy

      CLINICAL INFECTIOUS DISEASES
    95. McNeil, MM; Nash, SL; Hajjeh, RA; Phelan, MA; Conn, LA; Plikaytis, BD; Warnock, DW
      Trends in mortality due to invasive mycotic diseases in the United States,1980-1997

      CLINICAL INFECTIOUS DISEASES
    96. Hawley-Foss, N; Mbisa, G; Lum, JJ; Pilon, AA; Angel, JB; Garber, G; Badley, AD
      Effect of cessation of highly active antiretroviral therapy during a discordant response: Implications for scheduled therapeutic interruptions

      CLINICAL INFECTIOUS DISEASES
    97. Cacoub, P; Geffray, L; Rosenthal, E; Perronne, C; Veyssier, P; Raguin, G
      Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French departments of internal medicine/infectious diseases, in 1995 and 1997

      CLINICAL INFECTIOUS DISEASES
    98. Shevitz, AH; Knox, TA
      Nutrition in the era of highly active antiretroviral therapy

      CLINICAL INFECTIOUS DISEASES
    99. Hadigan, C; Meigs, JB; Corcoran, C; Rietschel, P; Piecuch, S; Basgoz, N; Davis, B; Sax, P; Stanley, T; Wilson, PWF; D'Agostino, RB; Grinspoon, S
      Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

      CLINICAL INFECTIOUS DISEASES
    100. Peltier, MR; Hansen, PJ
      Immunoregulatory activity, biochemistry, and phylogeny of ovine uterine serpin

      AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 18:11:23